ストックスクリーナーアプリを入手
31.16
1.02%
-0.32
プレマーケット:
30.85
-0.31
-0.99%
前日終値:
$31.48
開ける：
$31.35
24時間の取引高:
893.01K
Relative Volume:
0.96
時価総額：
$1.78B
収益：
$2.00B
当期純損益:
$-119.19M
株価収益率:
-14.23
EPS:
-2.19
ネットキャッシュフロー:
$-61.88M
1週間 パフォーマンス:
-8.94%
1か月 パフォーマンス:
-15.90%
6か月 パフォーマンス:
-23.59%
1年 パフォーマンス:
-44.85%
1日の値動き範囲:
$30.61
$31.69
1週間の範囲:
$30.61
$33.25
52週間の値動き範囲:
$29.32
$57.08
Enovis Corp Stock (ENOV) Company Profile
ENOV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
31.16 | 1.78B | 2.00B | -119.19M | -61.88M | -2.19 |
|
ABT
Abbott Laboratories
|
129.70 | 224.94B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.25 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.67 | 132.32B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.70 | 106.07B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.20 | 41.71B | 5.72B | 4.17B | 259.90M | 6.97 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-03 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-06-13 | 開始されました | JP Morgan | Neutral |
| 2024-02-13 | 開始されました | Stephens | Overweight |
| 2024-01-22 | 開始されました | UBS | Buy |
| 2024-01-03 | 開始されました | William Blair | Outperform |
| 2023-12-15 | 繰り返されました | Needham | Buy |
| 2023-10-20 | 開始されました | ROTH MKM | Buy |
| 2023-06-26 | 開始されました | Needham | Buy |
| 2023-05-12 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-10-11 | 開始されました | Goldman | Buy |
| 2022-09-12 | 開始されました | Canaccord Genuity | Buy |
| 2022-09-12 | 開始されました | Evercore ISI | Outperform |
| 2022-06-28 | 開始されました | Argus | Hold |
| 2022-06-27 | 再開されました | Loop Capital | Buy |
| 2022-06-16 | 開始されました | Wells Fargo | Equal Weight |
すべてを表示
Enovis Corp (ENOV) 最新ニュース
Enovis to Host First Quarter 2025 Results Conference Call on May 8th - The Manila Times
Enovis to Host First Quarter 2025 Results Conference Call on May 8th | ENOV Stock News - GuruFocus
Q1 2025 Earnings Preview: Enovis Readies Major Investor Update with Live Presentation May 8 - Stock Titan
Enovis Announces Third Quarter 2024 Results - ADVFN
Enovis’s Strategic Initiatives and Acquisitions Drive Buy Rating - TipRanks
Enovis names McDonald as CEO - MSN
Enovis appoints Damien McDonald as CEO - MedTech Dive
Enovis Appoints Damien McDonald CEO, Reaffirms Q1 Guidance Amid Strategic Growth Push - insights.citeline.com
Canaccord maintains Buy rating and $75 target for Enovis stock - Investing.com Australia
Enovis Receives Buy Rating Amidst Strategic Leadership Change and Strong Financial Projections - TipRanks
Canaccord maintains Buy rating and $75 target for Enovis stock By Investing.com - Investing.com India
Enovis’s Promising Future: Buy Rating Backed by Strategic Leadership and Positive Financial Outlook - TipRanks
Enovis names Damien McDonald as new CEO starting May 12 By Investing.com - Investing.com Canada
Enovis (ENOV) Appoints New CEO and Confirms Revenue Forecast - GuruFocus
Enovis Names Damien McDonald as New CEO to Drive Next Growth Chapter - MSN
Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Enovis (ENOV) and Auckland International Airport Limited (OtherACKDF) - The Globe and Mail
Enovis names Damien McDonald as CEO, succeeding Matt Trerotola - TipRanks
Strategic Leadership and Financial Stability Drive Buy Rating for Enovis - TipRanks
Enovis Appoints Damien McDonald as New CEO - TipRanks
Enovis Announces Appointment of Damien McDonald as Chief Executive Officer - Ortho Spine News
Enovis Corporation Reiterats Earnings Guidance for the First Quarter of 2025 - MarketScreener
Former LivaNova CEO to take corner office at Enovis - MassDevice
Enovis names Damien McDonald as new CEO starting May 12 - Investing.com Australia
Enovis Names Damien McDonald as Chief Executive; Reaffirms Q1 Revenue Guidance - MarketScreener
Enovis Appoints Damien McDonald as Chief Executive Officer - citybiz
Enovis Announces Appointment Of Damien Mcdonald As Chief Executive Officer - MarketScreener
Enovis Announces Appointment Of Damien McDonald As Chief Executive Officer - MarketScreener
Medical Device Expert Takes Helm at Enovis: Former LivaNova CEO to Drive Growth - Stock Titan
Enovis Corporation (NYSE:ENOV) Looks Inexpensive But Perhaps Not Attractive Enough - simplywall.st
2 Healthcare Stocks with Solid Fundamentals and 1 to Turn Down - The Globe and Mail
Enovis Showcases Innovative Foot and Ankle Solutions at ACFAS Conference - MSN
Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025 - GlobeNewswire
Enovis, Foundation Surgical and J&J MedTech Named Winners of OMTEC® Awards, Honoring Excellence in Orthopedic Innovation - Ortho Spine News
Revolutionary Bunion Surgery System Leads Enovis's Major Product Launch at ACFAS 2025 - Stock Titan
Enovis : trade; Publishes 2024 Corporate Social Responsibility Report - MarketScreener
Enovis Corp (ENOV) Stock Price Up 1.77% on Mar 19 - GuruFocus.com
Enovis Plans Leadership Change - The Healthcare Technology Report.
Enovis CEO Matthew Trerotola Announces Retirement Plan - TipRanks
Positive Outlook for Enovis: Strong Market Position and Strategic Growth Initiatives - TipRanks
Diabetic Footwear Market Demand : Identifying Key Growth Opportunities By 2032 | Enovis companies, Pilgrim - EIN News
Enovis Corporation Announces Participation in Upcoming Investor Conferences - MSN
Enovis Positioned for Growth: Buy Rating Highlights Strategic Execution and Undervaluation - TipRanks
Enovis Corp (ENOV) 財務データ
収益
当期純利益
現金流量
EPS
0.34%
0.62%
大文字化:
|
ボリューム (24 時間):